The UK Just Overhauled Veterinary Pricing. Here’s What It Actually Changes and Why US Vets Should Pay Attention.

On March 24, 2026, the UK’s Competition and Markets Authority concluded its two-and-a-half year investigation into veterinary services with a package of legally binding reforms that will change how practices operate, how prices are disclosed, and how pet owners interact with the veterinary market. The CMA described it as the most extensive review of veterinary services in a generation.

The headline — “vet prescription fees capped” — has been running across consumer media since the announcement. It is accurate but incomplete. The prescription fee cap is one piece of a much larger set of reforms that together represent a significant structural intervention in a sector the CMA values at more than £6.7 billion. For veterinary professionals — in the UK and elsewhere — the full picture is worth understanding.

What the investigation actually found

The CMA’s core finding was that veterinary prices in the UK rose at nearly twice the rate of inflation over the investigation period, and that pet owners were being systematically left without the information they needed to make informed decisions about their care.

Internal documents highlighted in the inquiry suggested some large veterinary businesses set pricing strategies on the basis that pet owners would not switch providers. That finding, that pricing behavior was shaped in part by an assumption of client inertia rather than competitive pressure, is the commercial reality the reforms are designed to disrupt.

Six large groups now control around 60% of all practices across the UK, but less than half of people using one of these groups knew their practice was part of a chain. The opacity around ownership was a specific finding, and transparency requirements around corporate structure are a direct response to it.

Less than 40% of veterinary practices currently have prices listed on their websites. That figure alone explains a significant amount of the friction pet owners experience when trying to compare costs before they are already committed to a treatment plan.

What is actually changing and when

The reforms are phased, with larger practices required to comply first and smaller independent practices given approximately three months additional lead time on most requirements.

The prescription fee cap is the most-reported measure. The new cap applies to written prescription fees, not all vet bills — the fee is capped at £21 for the first medicine and £12.50 for additional medicines, reduced from current fees of £30 or more at many practices. The distinction matters: treatment costs, consultations, procedures, and diagnostics are not capped. What is capped is the fee a practice can charge to issue a written prescription that allows a pet owner to purchase that medicine elsewhere, including online.

The CMA found that more than 70% of pet owners purchased long-term medications directly from their vet practice even though many could save £200 or more per year by using an online or third-party pharmacy. The prescription fee cap is designed to reduce the financial barrier to exercising that option.

Beyond prescription fees, the reforms require practices to publish comprehensive price lists for standard services — consultations, common procedures, diagnostics, cremation options — both online and on-site. Written estimates must be provided in advance for any treatment expected to cost £500 or more, with itemised bills provided after treatment. Emergency care is the only exception. Practices must also clearly disclose whether they are part of a larger group, both online and with visible signage at the practice itself.

A price comparison capability will be built through the Royal College of Veterinary Surgeons’ existing Find a Vet service, feeding pricing and ownership data to third-party comparison sites. The legally binding CMA orders are due by September 2026, with most measures taking effect within three to twelve months after that.

The profession’s response

The British Veterinary Association’s response was measured and largely constructive. BVA president Rob Williams said the majority of the CMA’s measures focus on increasing transparency and information, calling it a “really positive step,” while noting that delivering highly skilled veterinary medicine is costly and that practices have not been immune to rising costs.

Williams also made an argument worth taking seriously: advances in diagnostics and medical technology over the past two decades mean vets can now do far more to manage disease and injury in animals than was previously possible. Better medicine costs more than fewer options. The expectation from pet owners of human-quality healthcare for their animals is real, and meeting it has a genuine price.

CVS Group, which operates around 500 UK practices, said it believed some of the remedies were not fully justified but was comfortable with them and considered them workable — a measured response from the largest single operator in the sector.

What this means outside the UK

This is a UK regulatory story, but the underlying dynamics are not uniquely British.

The consolidation of veterinary practice ownership by large corporate groups is a global trend. The pricing transparency gap between what practices charge and what clients understand they are paying is not unique to the UK. The tension between the genuine cost of advanced veterinary medicine and the financial reality of pet ownership is something practitioners across the US, Australia, and Europe navigate daily.

The CMA’s intervention is notable because it represents a government’s considered response to a market failure in veterinary services — and that response is focused almost entirely on transparency and information rather than price controls on clinical care itself. The prescription fee cap is the exception, and it is targeted specifically at a mechanism that was being used to reduce client mobility rather than to fund clinical services.

Whether equivalent regulatory attention comes to veterinary markets in other countries likely depends on how loudly the access-to-care conversation gets in each one. In the US, that conversation is already happening. The data on how many pet owners delay or forgo veterinary care for financial reasons, and the downstream animal welfare consequences of that, are part of a growing policy discussion that did not exist in the same form a decade ago.

The UK just provided one model for how a regulator responds when it concludes the market is not working well enough on its own.

The CMA’s full final report on the veterinary services market investigation is available at gov.uk. Legally binding orders are expected by September 2026, with most reforms phased in within twelve months after that.